Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Halozyme Therapeutics
HALO
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 49.74%504.58M | 67.36%55.97M | 67.36%55.97M | -25.74%61.84M | -7.76%125.71M | 32.86%336.96M | -9.08%33.44M | -9.08%33.44M | 124.19%83.27M | 297.13%136.28M |
-Cash and cash equivalents | 49.74%504.58M | 67.36%55.97M | 67.36%55.97M | -25.74%61.84M | -7.76%125.71M | 32.86%336.96M | -9.08%33.44M | -9.08%33.44M | 124.19%83.27M | 297.13%136.28M |
Receivables | 13.40%307.87M | 14.08%300.71M | 14.08%300.71M | 118.13%292.08M | 139.43%280.9M | 149.47%271.49M | 155.01%263.6M | 155.01%263.6M | 41.75%133.9M | 37.37%117.32M |
-Accounts receivable | 24.18%184.52M | 26.02%177.47M | 26.02%177.47M | 26.18%168.95M | 34.58%157.88M | 36.54%148.59M | 36.23%140.82M | 36.23%140.82M | 41.75%133.9M | 37.37%117.32M |
-Loans receivable | 0.37%123.36M | 0.37%123.24M | 0.37%123.24M | --123.13M | --123.01M | --122.9M | --122.78M | --122.78M | ---- | ---- |
Prepaid assets | ---- | --0 | --0 | --0 | -85.63%1.25M | 120.00%7.98M | 30.77%2.13M | 30.77%2.13M | --0 | -52.91%8.7M |
Restricted cash | --50.11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | 42.91%880.94M | 19.22%356.68M | 19.22%356.68M | 62.97%353.92M | 55.49%407.86M | 61.24%616.42M | 111.01%299.17M | 111.01%299.17M | 55.34%217.17M | 89.80%262.3M |
Non current assets | ||||||||||
Goodwill and other intangible assets | -18.03%187.6M | 30.09%206.62M | 30.09%206.62M | 32.33%210.67M | 47.03%225.18M | 37.45%228.85M | -9.32%158.83M | -9.32%158.83M | -12.08%159.19M | -9.87%153.15M |
-Other intangible assets | -18.03%187.6M | 30.09%206.62M | 30.09%206.62M | 32.33%210.67M | 47.03%225.18M | 37.45%228.85M | -9.32%158.83M | -9.32%158.83M | -12.08%159.19M | -9.87%153.15M |
Financial assets | -66.66%5.58M | -9.64%8.94M | -9.64%8.94M | -84.16%3.88M | -16.91%16.51M | 140.92%16.74M | -13.36%9.9M | -13.36%9.9M | 94.94%24.49M | --19.87M |
Non current deferred assets | 12.42%72.05M | 11.23%69.83M | 11.23%69.83M | 18.16%71.51M | 20.15%70.87M | 22.74%64.09M | 25.78%62.78M | 25.78%62.78M | 26.23%60.52M | 37.58%58.99M |
Other non current assets | -6.26%20.73M | 6.89%26.96M | 6.89%26.96M | 7.15%34.09M | -2.91%18.5M | 1.39%22.11M | 1.01%25.23M | 1.01%25.23M | 14.17%31.82M | -2.35%19.06M |
Total non current assets | 3.74%12.2B | 15.62%12.29B | 15.62%12.29B | 16.47%12.07B | 20.05%11.96B | 19.36%11.76B | 16.60%10.63B | 16.60%10.63B | 18.28%10.36B | 28.71%9.96B |
Total assets | 5.69%13.09B | 15.72%12.65B | 15.72%12.65B | 17.42%12.42B | 20.95%12.37B | 20.92%12.38B | 18.04%10.93B | 18.04%10.93B | 18.87%10.58B | 29.78%10.23B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 1.65%247.28M | 16.44%247.53M | 16.44%247.53M | 11.77%264.37M | 31.35%248.58M | 28.28%243.28M | 33.25%212.58M | 33.25%212.58M | 36.17%236.53M | 37.10%189.25M |
-accounts payable | -4.65%142M | 16.19%149.71M | 16.19%149.71M | 9.01%169.08M | 40.15%153.99M | 35.05%148.92M | 32.15%128.84M | 32.15%128.84M | 36.33%155.1M | 34.42%109.88M |
-Dividends payable | 11.58%105.29M | 16.83%97.82M | 16.83%97.82M | 17.03%95.29M | 19.17%94.58M | 18.88%94.36M | 34.98%83.73M | 34.98%83.73M | 35.87%81.42M | 40.98%79.37M |
Current deferred liabilities | -11.34%178.87M | -9.31%181.27M | -9.31%181.27M | 61.87%185.2M | 55.65%192.64M | 66.29%201.76M | 115.74%199.87M | 115.74%199.87M | 27.48%114.42M | 56.47%123.76M |
Other current liabilities | --234K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Current liabilities | -4.19%426.39M | 3.97%428.8M | 3.97%428.8M | 28.11%449.57M | 40.96%441.21M | 43.11%445.04M | 63.56%412.45M | 63.56%412.45M | 33.21%350.94M | 44.15%313.01M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -0.03%3.35B | 50.32%3.35B | 50.32%3.35B | 50.39%3.35B | 50.36%3.35B | 50.14%3.35B | 14.95%2.23B | 14.95%2.23B | 15.18%2.23B | 34.12%2.23B |
-Long term debt | -0.03%3.35B | 50.32%3.35B | 50.32%3.35B | 50.39%3.35B | 50.36%3.35B | 50.14%3.35B | 14.95%2.23B | 14.95%2.23B | 15.18%2.23B | 34.12%2.23B |
Derivative product liabilities | ---- | ---- | ---- | --295K | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current liabilities | -20.40%136.66M | -0.06%147.47M | -0.06%147.47M | -0.16%155.33M | 24.98%163.11M | 24.11%171.69M | 0.12%147.56M | 0.12%147.56M | 0.47%155.58M | -12.75%130.51M |
Total non current liabilities | -1.02%3.48B | 47.19%3.49B | 47.19%3.49B | 47.10%3.51B | 48.95%3.51B | 48.57%3.52B | 13.90%2.37B | 13.90%2.37B | 14.09%2.38B | 30.25%2.36B |
Total liabilities | -1.38%3.91B | 40.79%3.92B | 40.79%3.92B | 44.67%3.96B | 48.02%3.95B | 47.93%3.97B | 19.26%2.79B | 19.26%2.79B | 16.23%2.73B | 31.74%2.67B |
Shareholders'equity | ||||||||||
Share capital | 0.12%158.04M | 0.08%157.93M | 0.08%157.93M | 0.08%157.87M | 0.11%157.85M | 0.11%157.85M | 0.15%157.8M | 0.15%157.8M | 0.15%157.74M | 0.19%157.69M |
-common stock | 8.45%2.36M | 6.12%2.25M | 6.12%2.25M | 6.30%2.2M | 8.36%2.18M | 8.47%2.18M | 12.27%2.12M | 12.27%2.12M | 13.09%2.07M | 17.48%2.01M |
-Preferred stock | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M | 0.00%155.68M |
Retained earnings | ---474.55M | -30.41%-441.88M | -30.41%-441.88M | ---- | ---- | ---- | -32.49%-338.84M | -32.49%-338.84M | ---- | ---- |
Paid-in capital | 10.72%9.12B | 8.32%8.6B | 8.32%8.6B | 9.27%8.32B | 12.64%8.24B | 12.79%8.23B | 19.47%7.94B | 19.47%7.94B | 21.72%7.61B | 31.58%7.31B |
Gains losses not affecting retained earnings | -74.27%3.58M | -5.94%6.75M | -5.94%6.75M | -93.03%1.47M | -16.28%13.83M | 346.65%13.92M | -13.04%7.17M | -13.04%7.17M | 129.23%21.14M | 655.65%16.53M |
Other equity interest | ---- | ---- | ---- | -27.33%-407.7M | -27.87%-381.51M | -35.37%-370.72M | ---- | ---- | -35.02%-320.18M | -37.76%-298.37M |
Total stockholders'equity | 9.57%8.8B | 7.17%8.32B | 7.17%8.32B | 8.01%8.07B | 11.66%8.03B | 11.79%8.03B | 18.45%7.77B | 18.45%7.77B | 20.82%7.47B | 30.81%7.19B |
Noncontrolling interests | -2.49%371.61M | 6.61%401.91M | 6.61%401.91M | 6.21%394.29M | 5.99%389.51M | 2.58%381.1M | 2.89%376.99M | 2.89%376.99M | 2.59%371.25M | 2.93%367.51M |
Total equity | 9.02%9.17B | 7.15%8.73B | 7.15%8.73B | 7.93%8.46B | 11.39%8.42B | 11.34%8.42B | 17.63%8.14B | 17.63%8.14B | 19.81%7.84B | 29.10%7.55B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |